| 发明名称 |
TREATMENT OF THROMBOCYTOPENIA USING ORALLY ADMINISTERED INTERFERON |
| 摘要 |
An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN. |
| 申请公布号 |
US2015132261(A1) |
申请公布日期 |
2015.05.14 |
| 申请号 |
US201314398647 |
申请日期 |
2013.04.30 |
| 申请人 |
AMARILLO BIOSCIENCES, INC. ;CYTOPHARM, INC. |
发明人 |
Cummins Martin Joseph;Yeh Chau-Ting;Lee Ching-Yuan |
| 分类号 |
A61K9/00;A61K38/21 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating thrombocytopenia in a human patient, said method comprising
identifying patients with platelet blood levels of less than 150,000 per microliter; orally administering interferon (IFN) to said patients to stimulate a more rapid increase in blood platelet count than is achieved without said oral administration of IFN. |
| 地址 |
Amarillo TX US |
